Corcept Therapeutics Inc
SWB:HTD

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
SWB:HTD
Watchlist
Price: 52.04 EUR -1.25%
Market Cap: 3.6B EUR
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Intrinsic Value

The intrinsic value of one HTD stock under the Base Case scenario is 103.64 EUR. Compared to the current market price of 52.04 EUR, Corcept Therapeutics Inc is Undervalued by 50%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HTD Intrinsic Value
103.64 EUR
Undervaluation 50%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Corcept Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for HTD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about CORT?
Bearish
Neutral
Bullish

Fundamental Analysis

52.04 EUR
-1.25%
-1.25%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Corcept Therapeutics Inc
US
Pharmaceuticals
Market Cap
5.7B USD
IPO
Apr 15, 2004
Employees
238
United States of America
Market Cap
5.7B USD
Industry
Pharmaceuticals
IPO
Apr 15, 2004
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Corcept Therapeutics Inc

Provide an overview of the primary business activities
of Corcept Therapeutics Inc.

What unique competitive advantages
does Corcept Therapeutics Inc hold over its rivals?

What risks and challenges
does Corcept Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Corcept Therapeutics Inc recently?

Summarize the latest earnings call
of Corcept Therapeutics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Corcept Therapeutics Inc.

Provide P/S
for Corcept Therapeutics Inc.

Provide P/E
for Corcept Therapeutics Inc.

Provide P/OCF
for Corcept Therapeutics Inc.

Provide P/FCFE
for Corcept Therapeutics Inc.

Provide P/B
for Corcept Therapeutics Inc.

Provide EV/S
for Corcept Therapeutics Inc.

Provide EV/GP
for Corcept Therapeutics Inc.

Provide EV/EBITDA
for Corcept Therapeutics Inc.

Provide EV/EBIT
for Corcept Therapeutics Inc.

Provide EV/OCF
for Corcept Therapeutics Inc.

Provide EV/FCFF
for Corcept Therapeutics Inc.

Provide EV/IC
for Corcept Therapeutics Inc.

Show me price targets
for Corcept Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Corcept Therapeutics Inc?

How accurate were the past Revenue estimates
for Corcept Therapeutics Inc?

What are the Net Income projections
for Corcept Therapeutics Inc?

How accurate were the past Net Income estimates
for Corcept Therapeutics Inc?

What are the EPS projections
for Corcept Therapeutics Inc?

How accurate were the past EPS estimates
for Corcept Therapeutics Inc?

What are the EBIT projections
for Corcept Therapeutics Inc?

How accurate were the past EBIT estimates
for Corcept Therapeutics Inc?

Compare the revenue forecasts
for Corcept Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Corcept Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Corcept Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Corcept Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Corcept Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Corcept Therapeutics Inc with its peers.

Analyze the financial leverage
of Corcept Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Corcept Therapeutics Inc.

Provide ROE
for Corcept Therapeutics Inc.

Provide ROA
for Corcept Therapeutics Inc.

Provide ROIC
for Corcept Therapeutics Inc.

Provide ROCE
for Corcept Therapeutics Inc.

Provide Gross Margin
for Corcept Therapeutics Inc.

Provide Operating Margin
for Corcept Therapeutics Inc.

Provide Net Margin
for Corcept Therapeutics Inc.

Provide FCF Margin
for Corcept Therapeutics Inc.

Show all solvency ratios
for Corcept Therapeutics Inc.

Provide D/E Ratio
for Corcept Therapeutics Inc.

Provide D/A Ratio
for Corcept Therapeutics Inc.

Provide Interest Coverage Ratio
for Corcept Therapeutics Inc.

Provide Altman Z-Score Ratio
for Corcept Therapeutics Inc.

Provide Quick Ratio
for Corcept Therapeutics Inc.

Provide Current Ratio
for Corcept Therapeutics Inc.

Provide Cash Ratio
for Corcept Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Corcept Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Corcept Therapeutics Inc?

What is the current Free Cash Flow
of Corcept Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Corcept Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Corcept Therapeutics Inc

Current Assets 467m
Cash & Short-Term Investments 380.3m
Receivables 59.7m
Other Current Assets 26.9m
Non-Current Assets 317.3m
Long-Term Investments 167.3m
PP&E 8.4m
Other Non-Current Assets 141.5m
Current Liabilities 126.2m
Accounts Payable 18.6m
Accrued Liabilities 107.6m
Non-Current Liabilities 19.2m
Other Non-Current Liabilities 19.2m
Efficiency

Earnings Waterfall
Corcept Therapeutics Inc

Revenue
628.6m USD
Cost of Revenue
-9.8m USD
Gross Profit
618.8m USD
Operating Expenses
-475.4m USD
Operating Income
143.4m USD
Other Expenses
-1.5m USD
Net Income
141.8m USD

Free Cash Flow Analysis
Corcept Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

HTD Profitability Score
Profitability Due Diligence

Corcept Therapeutics Inc's profitability score is 78/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
Positive 3-Year Average ROE
78/100
Profitability
Score

Corcept Therapeutics Inc's profitability score is 78/100. The higher the profitability score, the more profitable the company is.

HTD Solvency Score
Solvency Due Diligence

Corcept Therapeutics Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
80/100
Solvency
Score

Corcept Therapeutics Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HTD Price Targets Summary
Corcept Therapeutics Inc

Wall Street analysts forecast HTD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HTD is 74.17 EUR with a low forecast of 65.7 EUR and a high forecast of 81.55 EUR.

Lowest
Price Target
65.7 EUR
26% Upside
Average
Price Target
74.17 EUR
43% Upside
Highest
Price Target
81.55 EUR
57% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HTD?

Click here to dive deeper.

Dividends

Corcept Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CORT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CORT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one HTD stock?

The intrinsic value of one HTD stock under the Base Case scenario is 103.64 EUR.

Is HTD stock undervalued or overvalued?

Compared to the current market price of 52.04 EUR, Corcept Therapeutics Inc is Undervalued by 50%.

Back to Top